Evofem Biosciences Performance
| EVFMDDelisted Stock | 0.64 0.05 8.47% |
The firm shows a Beta (market volatility) of -3.31, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Evofem Biosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Evofem Biosciences is expected to outperform it. Evofem Biosciences right now shows a risk of 0.0%. Please confirm Evofem Biosciences maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if Evofem Biosciences will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Evofem Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Evofem Biosciences is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Evofem |
Evofem Biosciences Relative Risk vs. Return Landscape
If you would invest 64.00 in Evofem Biosciences on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Evofem Biosciences or generate 0.0% return on investment over 90 days. Evofem Biosciences is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Evofem, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Evofem Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evofem Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Evofem Biosciences, and traders can use it to determine the average amount a Evofem Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| EVFMD |
Based on monthly moving average Evofem Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Evofem Biosciences by adding Evofem Biosciences to a well-diversified portfolio.
Things to note about Evofem Biosciences performance evaluation
Checking the ongoing alerts about Evofem Biosciences for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Evofem Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Evofem Biosciences is not yet fully synchronised with the market data | |
| Evofem Biosciences has some characteristics of a very speculative penny stock |
- Analyzing Evofem Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Evofem Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Evofem Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Evofem Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Evofem Biosciences' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Evofem Biosciences' otc stock. These opinions can provide insight into Evofem Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Evofem OTC Stock
If you are still planning to invest in Evofem Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evofem Biosciences' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |